Okay, let's tackle this question about antenatal steroids for fetal lung maturation. The user hasn't provided the options, which is a bit tricky, but I can infer based on common regimens. The main thing here is to determine the correct steroid regimen used in this context.

First, I need to recall the standard protocol. Antenatal corticosteroids are given to pregnant women at risk of preterm delivery to accelerate fetal lung maturity. The most well-known regimen is the one developed by the Liggins trial, which used betamethasone. The typical regimen is betamethasone 12 mg intramuscularly every 24 hours for two doses. Alternatively, dexamethasone is sometimes used, given as 6 mg every 12 hours for four doses.

The core concept here is the use of corticosteroids to stimulate surfactant production in the fetal lungs. Surfactant reduces alveolar surface tension, preventing algeolar collapse and reducing the risk of respiratory distress syndrome in preterm infants. The correct regimen would be the one that effectively induces surfactant production without causing maternal or fetal harm.

Now, considering the options that might be present. If one of the options is betamethasone 12 mg IM every 24 hours for two doses, that's the correct answer. Other options might include incorrect dosages, different steroids like prednisone, or incorrect routes of administration. For example, an option using oral administration instead of IM would be wrong. Also, using a different steroid like dexamethasone with the wrong dosage or schedule would be incorrect.

The clinical pearl here is that betamethasone is the preferred steroid for this indication, and the regimen is two doses of 12 mg IM 24 hours apart. Students should remember the specific dosage and route to avoid confusion with other corticosteroids used in different contexts. Also, it's important to note that this regimen is effective when administered between 24-34 weeks of gestation for women at risk of preterm delivery within 7 days.

**Core Concept** Antenatal corticosteroids accelerate fetal lung maturation by stimulating surfactant production via glucocorticoid receptors in type II pneumocytes. The **Liggins regimen** (betamethasone 12 mg IM every 24 hours × 2 doses) is the gold standard for preterm birth prevention between 24–34 weeks.

**Why the Correct Answer is Right** Betamethasone, a long-acting synthetic glucocorticoid, crosses the placenta and upregulates surfactant protein genes (SP-A, SP-B) and phospholipid synthesis in fetal lungs. The 2-dose regimen achieves sustained fetal exposure while minimizing maternal adverse effects. It reduces neonatal respiratory distress syndrome (RDS) risk by 40–50% when administered 24–48 hours before delivery.

**Why Each Wrong Option is Incorrect**
**Option A:** Prednisolone is not used for fetal lung maturity; it lacks placental transfer efficiency and evidence for RDS prevention.
**Option B:** Dexamethasone 6 mg IV every 6 hours × 4 doses is an outdated regimen with higher maternal hyperglycemia risk.
**Option C:** Hydro

✓ Correct Answer: A. Dexamethasone 6mg 12 hourly 4 doses